Spinout News

Bioxydyn and QSA partner to provide advanced neurological clinical trials

2 August 2023

UCLB spinout Queen Square Analytics (QSA), has announced a partnership with Bioxydyn, Ltd. to provide advanced clinical trial services in the neurological treatment arena.

The partnership will see Bioxydyn and QSA jointly provide a comprehensive set of clinical trial services for multiple sclerosis (MS) and other neurological disorders.

Bruce Lynn, CEO of Queen Square Analytics Ltd., said: “Bioxydyn provides years of experience and operational capability to QSA’s latest innovations in applying machine learning and other advanced imaging technologies to clinical trials.”

Read the full story here.